UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062037
Receipt number R000067543
Scientific Title Optimization of sedentary time using a personalized digital-nudge JITAI app combined with a wearable device: a pilot AB-design single-case series in stable cardiovascular disease patients.
Date of disclosure of the study information 2026/06/24
Last modified on 2026/06/24 07:33:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An AB-design pilot study evaluating the effectiveness of a personalized smartphone intervention (JITAI) combined with a wearable device to optimize sedentary time in outpatients with heart disease

Acronym

Sit-Time Optimization App Study with heart disease

Scientific Title

Optimization of sedentary time using a personalized digital-nudge JITAI app combined with a wearable device: a pilot AB-design single-case series in stable cardiovascular disease patients.

Scientific Title:Acronym

Pilot study of Behavioral Engagement with Adaptive Tools for SITting Time with heart disease patients

Region

Japan


Condition

Condition

cardiovascular disease

Classification by specialty

Cardiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The primary objective of this study is to evaluate the feasibility and preliminary efficacy of an intervention combining a digital nudge-based JITAI app and wearable devices tailored to individual characteristics (TIPI-J) using a single-subject AB design targeting community-dwelling patients with stable cardiovascular disease, and to estimate the effect size to inform future RCT designs. The primary outcomes will be reductions in total daily sitting time and the cumulative duration of continuous sitting sessions lasting 30 minutes or longer. Secondary outcomes will include the number of times the participant stands up, step count, implementation and acceptability indicators (number of app launches, wear rate), patient-reported outcomes (KCCQ-12, fatigue VAS), and physiological indicators (resting heart rate). Safety will be assessed descriptively by monitoring the frequency of adverse events.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in mean daily sedentary time (min/day)
Timing: compare the last week of Phase A (pre-intervention, Week 2) with the last week of Phase B (after 4 weeks of intervention, Week 6); data source: Fitbit API, synced daily.

Key secondary outcomes

Sum of >= 30-minute prolonged sitting (min/day): change in weekly means between end of Phase A (Week 2) and end of Phase B (Week 6).

Sum of prolonged sitting >= 30 minutes (min/day): change in weekly means between end of Phase A (Week 2) and end of Phase B (Week 6).

Sit-to-stand counts (counts/day): same timing.

Steps (steps/day): same timing.

Resting heart rate (bpm): change from end of Phase A to end of Phase B, plus maintenance at 2 weeks after Phase B (Week 8; notification-off follow-up).

Implementation / acceptability: app launches (per day; averaged across 4 weeks of Phase B) and wear adherence (%; proportion of prescribed wear time from 09:00 to 21:00).

Patient-reported outcomes (PROs): KCCQ-12 (total and domain scores) and fatigue VAS at registration, weekly, and 2 weeks after Phase B (Week 8).

User experience: SUS score and a semi-structured interview at the end of Phase B (Week 6).

Safety: frequency and severity of adverse events (exercise-related, cardiovascular, device-related, skin irritation). Cumulative from start of Phase A through end of follow-up (Week 8); Phase B breakdown as needed.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom Other

Interventions/Control_1

Name: Personalized JITAI smartphone intervention plus wrist-worn wearable
Category: Behavioral (digital health), device use
Exposure window: 4 weeks during Phase B (Phase A is 2-week observation without notifications; notifications are turned off for 2-week post-B follow-up)
Components:

A JITAI smartphone app delivers 0 to 3 prompts per day, tailored by real-time activity and baseline personality assessment (TIPI-J)

Prompts are triggered when prolonged sitting reaches 30 minutes or when overall activity is low, encouraging brief sit-to-stand and short walks

A wrist-worn wearable continuously captures daytime activity and syncs to the app
Use instructions: Wear and run the app primarily from 09:00 to 21:00. Study staff provide onboarding and safety checks; no scheduled human coaching during the intervention
Comparator: Within-subject self-control. Weekly means during Phase A (observation, no notifications) are compared with Phase B (intervention)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Recruiting patients with stable cardiovascular disease who live in the local area (and have not been hospitalized for at least 12 months)

Inclusion Criteria
1. Smartphone user who routinely uses the communication app LINE
2. Independent in activities of daily living
3. Agrees to wear a wearable device

Key exclusion criteria

1. Patients with dementia
2. Patients with atrial fibrillation (as Fitbit pulse measurements may be inaccurate)

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Koichi
Middle name
Last name Naito

Organization

Nagoya Aoi University

Division name

Department of Physical Therapy, Faculty of Medical Science

Zip code

4678610

Address

3-40 Shioji-cho, Mizuho-ku, Nagoya, Aichi, Japan

TEL

0528385026

Email

naito@nagoya-aoi.ac.jp


Public contact

Name of contact person

1st name Koichi
Middle name
Last name Naito

Organization

Nagoya Aoi University

Division name

Department of Physical Therapy, Faculty of Medical Science

Zip code

4678610

Address

3-40 Shioji-cho, Mizuho-ku, Nagoya, Aichi, Japan

TEL

0528385026

Homepage URL


Email

naito@nagoya-aoi.ac.jp


Sponsor or person

Institute

Nagoya Aoi University

Institute

Department

Personal name

Koichi Naito


Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nagoya City University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya Aoi University Institutional Review Board for Human Researc

Address

3-40 Shioji-cho, Mizuho-ku, Nagoya, Aichi, Japan

Tel

05288521111

Email

somu@nagoya-aoi.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

愛知県


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 06 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

8

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 10 Month 01 Day

Date of IRB

2025 Year 10 Month 01 Day

Anticipated trial start date

2026 Year 02 Month 01 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 06 Month 24 Day

Last modified on

2026 Year 06 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067543